Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Biotechnology

Healthcare
$1.61 -0.87%

-$0.02 today

Market cap
$80.25M
Beta
0.00
P/E (TTM)
-16.7
EPS (TTM)
-$0.14
52W Low $2.01High $48.91

Volume 0.02M

Average 0.34M

PLYX Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

Polaryx Therapeutics, Inc. Common StockNASDAQ: PLYX

Effect of Forex Changes · Q4 FY2025 · quarter ended Dec 2025

Effect of forex changes outflow grows to $0

Q4 FY2025 effect of forex changes was $0, compared with $0 a year earlier.

Context

  • Effect of forex changes increased in 0 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Effect of Forex Changes past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Effect of Forex Changes history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Effect of Forex Changes vs competitors

How PLYX compares with its peers on the latest reported figures

  • PLYX's FY2025 effect of forex changes of $0 is the 6th largest of the 8 companies compared; the peer median is $2K.
PLYX Competitors Peer median
Effect of Forex Changes for PLYX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
JBIOJade Biosciences, Inc.LTM Mar 2026$52.83M ———
CBIOCrescent Biopharma, Inc.LTM Mar 2026$23.94M +157.3%—201.5%
FHTXFoghorn Therapeutics Inc.LTM Mar 2026$292K ——1.0%
PTHSPelthos Therapeutics Inc.LTM Mar 2026$72.59K ——0.3%
LYELLyell Immunopharma, Inc.LTM Mar 2026$2K -99.9%—6.5%
PLYXPolaryx Therapeutics, Inc. Common StockFY2025$0 ———
ANTXAN2 Therapeutics, Inc.LTM Mar 2026$0 ———
KLRSKalaris Therapeutics IncLTM Mar 2026$0 ———
Peer median (excluding PLYX) $2K+28.7%—3.7%

Competitors are the stored peer set for PLYX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

Intrinsic Alpha fair value

Locked

Current Price

$1.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.